{
Novartis AG

Companies

}
Very Negative
Negative
Neutral
Positive
Very Positive
2025-03-312025-03-312025-04-032025-04-03115118866442200
Download SVG
Download PNG
Download CSV
Somewhat Relevant
Moderately Relevant
Very Relevant
Highly Relevant
2025-03-312025-03-312025-04-032025-04-03421118866442200
Download SVG
Download PNG
Download CSV

Divi's Labs Shares Drop as US Court Allows Generic Entresto Launch

Divi's Laboratories Ltd's shares fell nearly 3% on December 5, trading at Rs 6,078.6, after a US court ruled that Novartis could not block MSN Pharmaceuticals from launching a generic version of its heart drug, Entresto. The court upheld a previous decision that Novartis was unlikely to win a patent lawsuit against MSN, paving the way for the first US generic of the drug. Divi's Labs has a contract with Novartis for the drug, and its market capitalization stands at Rs 1.6 lakh crore.
Moneycontrol
United States Dollar DIVI'S LABORATORIES LTD Novartis AG MSN Pharmaceuticals IND USA Show more
Regulatory & Legal, Market Report
05:46 05.12.2024

Global Generic Pharmaceuticals Market Sees Growth in Simple Generics and Biosimilars

India's "Pharmaceuticals Mission" aims to boost generic production, with simple generics leading the market due to cost-effectiveness and ease of manufacturing. Cardiovascular diseases drive demand, while small molecules dominate product types. Retail pharmacies remain the preferred distribution channel, and key players like Cipla and Teva are expanding their offerings.
GlobeNewswire News Room
United States Dollar Euro Fresenius Kabi AG Sanofi Aspen Pharmacare Holdings Ltd Sun Pharmaceuticals, Ltd. Aurobindo Pharma Limited Glenmark Pharmaceuticals Limited Pfizer Inc. Lupin Limited Dr. Reddy's Laboratories Limited Zydus Lifesciences Limited Teva Pharmaceuticals, Inc. Viatris Inc. Novartis AG Hikma Cipla Limited IND USA Show more
Healthcare, Market Report
16:30 04.12.2024

Janux Therapeutics Shares Soar on Promising Prostate Cancer Drug Results

Janux Therapeutics' shares soared nearly 75% after promising early-stage results for its prostate cancer drug, JANX007, which targets metastatic, castration-resistant prostate cancer. In a small trial, 16 patients showed significant reductions in prostate-specific antigens, with mild side effects reported. Analysts are optimistic about the drug's potential, raising share price targets as Janux prepares for further trials.
BioPharma Dive
United States Dollar Novartis AG Janux Therapeutics, Inc. USA Matt Phipps Jeffrey La Rosa
Healthcare, Market Report
01:00 03.12.2024

swiss economy adapts as pharmaceuticals rise amid strong franc challenges

[Bloomberg]
SWI swissinfo.ch
Swiss Franc Euro United States Dollar Roche Holding AG Novartis AG Lonza Group AG Sandoz Group AG CHE DEU DNK USA David Marmet Maeva Cousin Alexander Koch Guy Parmelin Martin Schlegel Show more
Healthcare, Market Report
07:00 30.11.2024

Swiss stock market ends week positively amid mixed economic signals

The Swiss stock market closed positively on Friday, with the SMI rising 0.46% to 11,762.20 points, buoyed by Wall Street's gains. In the Eurozone, inflation increased to 2.3% in November, while Switzerland's GDP grew by 0.2%. Notable stock movements included ABB (+1.6%) and SIG Group (-1.5%).
agefi.com
Swiss Franc Euro United States Dollar Swisscom AG PIERER Mobility AG Novartis AG The Swatch Group AG RICHEMONT, Intellectual Property Services Cicor Bank of America Corporation UBS ABB Ltd Dottikon ES Holding AG Hoffmann-La Roche AG Lonza Group AG Julius Bär SIG Group AG Sandoz Group AG Nestlé S.A. CHE Laurent Perves Jérôme Lambert Louis Ferla Show more
TradFi, Market Report
18:02 29.11.2024

Citi names Divi's Labs top pharma pick with 15 percent upside potential

Divi's Laboratories has been named Citi's top pick in the Indian pharma sector, with a price target of Rs 6,850, indicating a potential upside of 15%. The company's shares have surged over 52% year-to-date, bolstered by a favorable US court ruling regarding a generic version of Novartis' heart failure drug, Entresto, which could have impacted Divi's sales. The CDMO contract with Novartis accounts for approximately 8% of Divi's total sales for FY24.
Moneycontrol
United States Dollar DIVI'S LABORATORIES LTD Novartis AG IND
Healthcare, Market Report
04:38 29.11.2024

Swiss stock market shows mixed results amid thin trading and holiday effects

The Swiss stock market closed mostly higher on November 28, 2024, with the SMI rising 0.57% to 11,709.80 points, despite a lack of significant market-moving news. Julius Baer led gains with a 2.1% increase, while technology stocks like Logitech also performed well amid easing US interest rates. Conversely, Swatch Group and Richemont saw declines, reflecting ongoing challenges in the luxury sector.
Finanz und Wirtschaft
Swiss Franc VAT Swiss Re AG Logitech International S.A. ABB Ltd Nestlé S.A. Givaudan SA Sonova Holding AG Hoffmann-La Roche AG RICHEMONT, Intellectual Property Services Straumann Holding AG Carlo Gavazzi Holding AG Holcim AG Adecco Group AG UBS Pierer Mobility Sika AG Novartis AG The Swatch Group AG Partners Group Holding AG Sandoz Group AG Sunrise CHE Show more
TradFi, Market Report
08:07 28.11.2024

europe's venture capital landscape drives innovation in sustainability and healthcare

Europe is emerging as a vibrant hub for venture capital, driven by a surge in sustainability and climate technology investments. Regions like 'Swiss Valley' and the 'Silicon Canals' are fostering innovation, particularly in healthcare and biotech, as established companies acquire startups to enhance their portfolios. With a growing focus on ESG criteria, the landscape is ripe for transformative breakthroughs that promise both financial returns and societal impact.
Asset Management
Euro Swiss Franc United States Dollar Novo Nordisk A/S Boehringer Ingelheim KG Novartis AG Johnson & Johnson Hoffmann-La Roche AG Oatly Group AB Ironwood Pharmaceuticals, Inc. CHE SWE NLD GBR Michael Brunner Erasmus Elsner Show more
TradFi, Market Report
04:16 28.11.2024

europe's venture capital landscape drives innovation in sustainability and healthcare

Europe is emerging as a vibrant hub for venture capital, driven by a surge in sustainability and climate technology investments. Regions like 'Swiss Valley' and the 'Silicon Canals' are fostering innovation, particularly in healthcare and biotech, as established companies acquire startups to enhance their portfolios. With a growing focus on ESG criteria, the landscape is ripe for transformative breakthroughs that promise both financial returns and societal impact.
Asset Management
Euro United States Dollar Swiss Franc British Pound Sterling Novartis AG Novo Nordisk A/S Ironwood Pharmaceuticals, Inc. Hoffmann-La Roche AG Boehringer Ingelheim KG Johnson & Johnson Oatly Group AB NLD SWE GBR CHE Erasmus Elsner Michael Brunner Show more
Finance & Economy, Market Report
04:16 28.11.2024

europe's venture capital landscape drives innovation in sustainability and healthcare

Europe is emerging as a vibrant hub for venture capital, driven by a surge in sustainability and climate technology investments. Regions like 'Swiss Valley' and the 'Silicon Canals' are fostering innovation, particularly in healthcare and biotech, as established companies acquire startups to enhance their portfolios. With a growing focus on ESG criteria, the landscape is ripe for transformative breakthroughs that promise both financial returns and societal impact.
Asset Management
Euro United States Dollar Novo Nordisk A/S Boehringer Ingelheim KG Novartis AG Johnson & Johnson Hoffmann-La Roche AG Oatly Group AB Ironwood Pharmaceuticals, Inc. GBR SWE NLD CHE Peter Pilavachi Show more
TradFi, Market Report
20:45 27.11.2024
Trending
Subcategory
Stock Market Updates Corporate News Industry Trends Global Trade Developments Global Financial Events Finance Mergers & Acquisitions Banking Regulations Retail and Consumer Goods Startups & Entrepreneurship Central Bank Actions Industry Mergers & Acquisitions Inflation and Monetary Impact Government Economic Policies CEO Changes Market Analysis and Predictions Domestic Politics Government Policies Workplace Trends GDP Growth & Recession Forecasts Financial Scams and Security
Countries:
USA CHN CHE GBR IND DEU FRA JPN CAN VNM ESP ITA ARE SGP MEX TWN AUS THA MYS EGY
Companies:
JPMorgan Chase & Co. Apple Inc. Tesla, Inc. Barclays PLC Deutsche Bank Money Market PP The Goldman Sachs Group, Inc. Credit Suisse Strategic Income I Banco Santander, S.A. Berkshire Hathaway Inc. UBS Group AG Lloyds Banking Group plc SpaceXCoin USD Morgan Stanley Amazon.com, Inc. Bank of America Corporation Wells Fargo & Company BNP Paribas SA NVIDIA Corporation Bank Frick AG UniCredit S.p.A.
Currencies:
United States Dollar Euro Swiss Franc British Pound Sterling Japanese Yen Indian Rupee Chinese Yuan Vietnamese Đồng South Korean Won Canadian Dollar Australian Dollar Thai Baht New Taiwan Dollar Singapore Dollar Indonesian Rupiah Mexican Peso Cambodian Riel Russian Ruble Hong Kong Dollar Offshore Chinese Yuan
People:
Donald Trump Elon Musk Warren Buffett JD Vance Sergio Ermotti Mark Haefele Robin Leopold Olivier Calvet Troy L Rohrbaugh Jennifer Piepszak Karoline Leavitt Ursula von der Leyen Scott Bessent Stacey Friedman George Saravelos Alex Kramm Susan P. Crawford Francois Xavier Bouvignies Joseph Spak Stefan Rauti

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.